Wedbush Reiterates Outperform Rating on Kiniksa Pharmaceuticals, Ltd. (KNSA)
Rating Change Wedbush analysts reiterated a Outperform rating on Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) on June 29, 2026. Market Context Kiniksa Pharmaceuticals, Ltd.
Read more
